SCHEMBL13025835

SCHEMBL13025835

CCc1ccc(CCC(F)(F)Oc2ccc(-c3ccc(C)cc3)c(F)c2C(F)F)cc1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 2/20 0.33
▸ S1PR1 P21453 1/20 0.32
▸ TP53 P04637 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ FFAR1 O14842 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14432887 0.91 FFAR4 (0.33) FFAR4S1PR1TP53MAPTFFAR1
SCHEMBL13025808 0.80 — —
SCHEMBL13025850 0.80 FFAR4 (0.32) FFAR4S1PR1FFAR1
SCHEMBL13025827 0.80 CASR (0.30) —
SCHEMBL13066716 0.79 CASR (0.32) —
SCHEMBL13025767 0.78 HCRTR1 (0.35) FFAR4S1PR1FFAR1
SCHEMBL13025929 0.76 S1PR1 (0.32) S1PR1
SCHEMBL13025747 0.76 RXRA (0.34) FFAR4S1PR1
SCHEMBL13025913 0.74 — —
SCHEMBL14362953 0.74 HCRTR1 (0.36) FFAR4S1PR1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7838087-B2 Benzene derivative, liquid crystal composition and liquid crystal display device CHISSO CORPORATION (JP) 2010-11-23 — — US disclosed
US-7838087-B2 Benzene derivative, liquid crystal composition and liquid crystal display device CHISSO CORPORATION (JP) 2010-11-23 — — US disclosed
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device JNC PETROCHEMICAL CORPORATION (JP) 2007-08-30 — — US disclosed
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device JNC PETROCHEMICAL CORPORATION (JP) 2007-08-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device CCND2, YBX1, CNKSR1 FFAR4 3309/4885S1PR1 2088/4885TP53 1140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback